Real-life data of major and minor bleeding events with direct oral anticoagulants in the one-year follow-up period: The NOAC-TURK study.

Creative Commons License

Gedikli Ö., Altay S., Ünlü S., Çakmak H. A., Aşkın L., Yanık A., ...Daha Fazla

Anatolian journal of cardiology, cilt.25, ss.196-204, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25
  • Basım Tarihi: 2021
  • Doi Numarası: 10.5152/anatoljcardiol.2021.57635
  • Dergi Adı: Anatolian journal of cardiology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.196-204
  • Anahtar Kelimeler: direct oral anticoagulants, major bleeding, minor bleeding, real-life data, non-valvular atrial fibrillation, EURO HEART SURVEY, ATRIAL-FIBRILLATION, WARFARIN, RISK, APIXABAN, RIVAROXABAN, MANAGEMENT, REGISTRY, STROKE
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Objective: This study aimed to evaluate the safety of direct oral anticoagulants (DOACs) in patients with non-valvular atrial fibrillation (NVAF) during daily clinical practice.